Literature DB >> 28820582

Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.

Kwang Hun Lim1, Anvesh K R Dasari1, Renze Ma2, Ivan Hung3, Zhehong Gan3, Jeffery W Kelly4, Michael C Fitzgerald2.   

Abstract

Amyloid formation of natively folded proteins involves global and/or local unfolding of the native state to form aggregation-prone intermediates. Here we report solid-state nuclear magnetic resonance (NMR) structural studies of amyloid derived from wild-type (WT) and more aggressive mutant forms of transthyretin (TTR) to investigate the structural changes associated with effective TTR aggregation. We employed selective 13C labeling schemes to investigate structural features of β-structured core regions in amyloid states of WT and two mutant forms (V30M and L55P) of TTR. Analyses of the 13C-13C correlation solid-state NMR spectra revealed that WT TTR aggregates contain an amyloid core consisting of nativelike CBEF and DAGH β-sheet structures, and the mutant TTR amyloids adopt a similar amyloid core structure with nativelike CBEF and AGH β-structures. However, the V30M mutant amyloid was shown to have a different DA β-structure. In addition, strand D is more disordered even in the native state of L55P TTR, indicating that the pathogenic mutations affect the DA β-structure, leading to more effective amyloid formation. The NMR results are consistent with our mass spectrometry-based thermodynamic analyses that showed the amyloidogenic precursor states of WT and mutant TTRs adopt folded structures but the mutant precursor states are less stable than that of WT TTR. Analyses of the oxidation rate of the methionine side chain also revealed that the side chain of residue Met-30 pointing between strands D and A is not protected from oxidation in the V30M mutant, while protected in the native state, supporting the possibility that the DA β-structure might be disrupted in the V30M mutant amyloid.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28820582      PMCID: PMC5745580          DOI: 10.1021/acs.biochem.7b00658

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  64 in total

1.  Selective and extensive 13C labeling of a membrane protein for solid-state NMR investigations.

Authors:  M Hong; K Jakes
Journal:  J Biomol NMR       Date:  1999-05       Impact factor: 2.835

Review 2.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 3.  Advanced solid-state NMR approaches for structure determination of membrane proteins and amyloid fibrils.

Authors:  Ming Tang; Gemma Comellas; Chad M Rienstra
Journal:  Acc Chem Res       Date:  2013-05-10       Impact factor: 22.384

Review 4.  Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?

Authors:  S K Palaninathan
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A.

Authors:  C C Blake; M J Geisow; S J Oatley; B Rérat; C Rérat
Journal:  J Mol Biol       Date:  1978-05-25       Impact factor: 5.469

6.  Magic-angle-spinning NMR techniques for measuring long-range distances in biological macromolecules.

Authors:  Mei Hong; Klaus Schmidt-Rohr
Journal:  Acc Chem Res       Date:  2013-02-07       Impact factor: 22.384

7.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.

Authors:  Jennifer Stine Elam; Alexander B Taylor; Richard Strange; Svetlana Antonyuk; Peter A Doucette; Jorge A Rodriguez; S Samar Hasnain; Lawrence J Hayward; Joan Selverstone Valentine; Todd O Yeates; P John Hart
Journal:  Nat Struct Biol       Date:  2003-06

8.  Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Authors:  Jun-Xia Lu; Wei Qiang; Wai-Ming Yau; Charles D Schwieters; Stephen C Meredith; Robert Tycko
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

9.  Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.

Authors:  E Ihse; A Ybo; Ob Suhr; P Lindqvist; C Backman; P Westermark
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

10.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

View more
  11 in total

1.  Inhibition of amyloid beta fibril formation by monomeric human transthyretin.

Authors:  Kanchan Garai; Ammon E Posey; Xinyi Li; Joel N Buxbaum; Rohit V Pappu
Journal:  Protein Sci       Date:  2018-03-14       Impact factor: 6.725

2.  NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations.

Authors:  Benjamin I Leach; Xin Zhang; Jeffery W Kelly; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2018-07-18       Impact factor: 3.162

3.  Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.

Authors:  Anvesh K R Dasari; Ivan Hung; Zhehong Gan; Kwang Hun Lim
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-24       Impact factor: 3.036

4.  Kinetic analysis of the multistep aggregation pathway of human transthyretin.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 5.  Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.

Authors:  Jin-Beom Si; Bokyung Kim; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

6.  Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.

Authors:  Anvesh K R Dasari; Robert M Hughes; Sungsool Wi; Ivan Hung; Zhehong Gan; Jeffrey W Kelly; Kwang Hun Lim
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

7.  Probing conformational changes of monomeric transthyretin with second derivative fluorescence.

Authors:  Denisa Jazaj; Seyyed Abolghasem Ghadami; Francesco Bemporad; Fabrizio Chiti
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

8.  Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo.

Authors:  Anvesh K R Dasari; Ivan Hung; Brian Michael; Zhehong Gan; Jeffery W Kelly; Lawreen H Connors; Robert G Griffin; Kwang Hun Lim
Journal:  Biochemistry       Date:  2020-04-30       Impact factor: 3.162

9.  Biophysical characterization and modulation of Transthyretin Ala97Ser.

Authors:  Yo-Tsen Liu; Yueh-Jung Yen; Frans Ricardo; Yu Chang; Pei-Hao Wu; Shing-Jong Huang; Kon-Ping Lin; Tsyr-Yan Yu
Journal:  Ann Clin Transl Neurol       Date:  2019-09-10       Impact factor: 4.511

10.  Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.

Authors:  Shuangyan Zhou; Jie Cheng; Ting Yang; Mingyue Ma; Wenying Zhang; Shuai Yuan; Glenn V Lo; Yusheng Dou
Journal:  Biomolecules       Date:  2019-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.